BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
The EWS/FLI translocation product is the causative oncogene in Ewing sarcoma and acts as an aberrant transcription factor. EWS/FLI dysregulates gene expression during tumorigenesis by abnormally activating or repressing genes. The expression levels of thousands of genes are affected in Ewing sarcoma...
Guardado en:
Autores principales: | Elizabeth T Wiles, Bianca Lui-Sargent, Russell Bell, Stephen L Lessnick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6116bd5bc3a94646a34c47a8b40bb2a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
por: Maria E. Gierisch, et al.
Publicado: (2019) -
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
por: Krishna Priya Thangaretnam, et al.
Publicado: (2017) -
EWS–FLI1‐targeting peptide identifies Ewing sarcoma tumor boundaries and lymph node metastasis via near‐infrared imaging
por: Yu Wang, et al.
Publicado: (2021) -
Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
por: Noelia Agra, et al.
Publicado: (2013) -
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma.
por: Davis T Weaver, et al.
Publicado: (2021)